Previous 10 | Next 10 |
Gainers: Aesthetic Medical International (AIH) +14%, Acorda Therapeutics (ACOR) +13%, Outlook Therapeutics (OTLK) +12%, Organovo (ONVO) +12%, Asensus Surgical (ASXC) +11%.Losers: Atea Pharmaceuticals (AVIR) -7%, Inotiv (NOTV) -7%, Lava Th...
Inotiv (NOTV) prices its offering of 2,647,059 shares for $17.00/share, for gross proceeds of ~$45.0MThe offering is expected to close on April 23, 2021.Shares -7% premarket.Previously (April 20): Inotiv proposes public offering to finance acquisitions of Bolder BioPATH and HistoTox...
WEST LAFAYETTE, Ind., April 21, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”) , a leading contract research organization specializing in nonclinical and analytical drug discovery and d...
Inotiv (NOTV) intends to offer and sell its common shares in an underwritten public offering. Underwriter's a 30-day option to purchase up to an additional 15% shares. Actual size or terms of the proposed offering.Company intends to use the net proceeds, together with its existing cash a...
WEST LAFAYETTE, Ind., April 20, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”) , a leading contract research organization specializing in nonclinical and analytical drug discovery and d...
WEST LAFAYETTE, Ind., April 20, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”) , a leading contract research organization specializing in nonclinical and analytical drug discovery and d...
Inotiv (NOTV) plans to expand its St. Louis operations to provide comprehensive and integrated services to support its planned acquisitions of HistoTox Labs and Bolder BioPATH.The Company plans to exercise its option to buy the St. Louis facility for ~$4.7M and complete an expansion contingen...
WEST LAFAYETTE, Ind., April 19, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”) , a leading contract research organization specializing in nonclinical and analytical drug discovery and d...
Inotiv (NOTV) has entered into an agreement and plan of merger with Bolder BioPATH, a contract pharmacology and pathology company.Bolder BioPATH specializes in in vivo models of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diseases of the central ...
WEST LAFAYETTE, Ind., April 16, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”) , a leading provider of non-clinical and analytical contract research services, today announced that the C...
News, Short Squeeze, Breakout and More Instantly...
WEST LAFAYETTE, Ind., June 10, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and rela...